At Salubris Biotherapeutics, Inc. (SalubrisBio)
We are developing innovative and transformative therapeutic molecules to provide clinically meaningful improvements in disease burden and quality of life for patients with significant unmet medical needs.
What We Do
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
SalubrisBio is advancing potential treatments to address the three leading causes of death in the world today: cardiovascular disease, cancer and neurodegenerative diseases.
We are a team of biotech industry experts brought together by our passion and commitment to excellence in the discovery and development of novel therapies.